Cargando…

An Unusual Etiology for Elevation of Activated Partial Thromboplastin Time (aPTT) in SLE: Acquired Hemophilia and Lupus Anticoagulant

A 60-year-old female who has a history significant for diabetes, depression, and rheumatoid arthritis presented with a progressively enlarging hematoma of the left upper extremity. She was found to have an enlarging hematoma and an isolated elevation of activated partial thromboplastin time (aPTT)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Seethala, Srikanth, Collins, Nathaniel P., Comerci, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3803140/ https://www.ncbi.nlm.nih.gov/pubmed/24191205 http://dx.doi.org/10.1155/2013/521785

Ejemplares similares

Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients
por: Bachler, Mirjam, et al.
Publicado: (2019)

Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?
por: Bronić, Ana, et al.
Publicado: (2021)

Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing
por: Smit, Bob, et al.
Publicado: (2023)

Patient with lupus anticoagulant caused aPTT prolongation corrected with prednisolone treatment and later anticoagulation treatment due to chronic atrial fibrillation
por: Frydrysiak, Marlena, et al.
Publicado: (2023)

Monitoring Anticoagulation with Unfractionated Heparin on Renal Replacement Therapy. Which is the Best aPTT Sampling Site?
por: Anton, Florin Ioan, et al.
Publicado: (2020)

Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation
por: Shin, Dong-Yeop, et al.
Publicado: (2015)

The First-Derivative Curve of the Coagulation Waveform Reveals the Cause of aPTT Prolongation
por: Shimomura, Daiki, et al.
Publicado: (2020)

The biphasic aPTT waveform to diagnose sepsis in patients with systemic inflammatory response syndrome
por: Hagg, D, et al.
Publicado: (2007)

Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement
por: Lardinois, Benjamin, et al.
Publicado: (2022)

Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)
por: Zhang, Lin, et al.
Publicado: (2020)

Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor
por: Matsumoto, Takeshi, et al.
Publicado: (2019)

Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients
por: Tokutake, Takayoshi, et al.
Publicado: (2016)

Assessment of aPTT-based clot waveform analysis for the detection of haemostatic changes in different types of infections
por: Tan, Chuen Wen, et al.
Publicado: (2020)

Association of aPTT-Guided Anticoagulation Monitoring with Thromboembolic Events in Patients Receiving V-A ECMO Support: A Systematic Review and Meta-Analysis
por: Rajsic, Sasa, et al.
Publicado: (2023)

Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis
por: Trudzinski, Franziska C., et al.
Publicado: (2016)

Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy
por: Byun, Jung-Hyun, et al.
Publicado: (2016)

Postpartum Acquired Hemophilia: A Rare Cause of Postpartum Hemorrhage
por: Seethala, Srikanth, et al.
Publicado: (2013)

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform
por: Katayama, Haruna, et al.
Publicado: (2018)

Unusual Initial Manifestation of Acquired Hemophilia A: A Normal Activated Partial Thromboplastin Time, Intramuscular Hematoma and Cerebral Hemorrhage
por: Tsuyama, Nobuaki, et al.
Publicado: (2016)

Determination of Biological Activity of Recombinant Reteplase Using Clot Lysis Time and Activated Partial Thromboplastin Time (APTT) Lysis Methods: A Comparative Study
por: Babaee, Tahereh, et al.
Publicado: (2018)

Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation
por: Ferrazzi, Paola, et al.
Publicado: (2010)

Acquired hemophilia A in the setting of dual anticoagulation therapy and lupus anticoagulant: a case report
por: Chen, Victor, et al.
Publicado: (2022)

Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: A retrospective analysis
por: Kanouchi, Kazunori, et al.
Publicado: (2021)

Anesthetic Management Using Epidural Analgesia for Emergency Laparoscopic Cholecystectomy in a Patient with Lupus Anticoagulant Positivity and Prolonged Activated Partial Thromboplastin Time
por: Watanabe, Yasuhiro, et al.
Publicado: (2022)

Anticoagulation in syncardia total artificial heart recipients: anti-factor Xa or activated partial thromboplastin time?
por: Monteagudo-Vela, María, et al.
Publicado: (2021)

Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays
por: Thomas, Owain, et al.
Publicado: (2015)

Aromatic Amines Exert Contrasting Effects on the Anticoagulant Effect of Acetaldehyde upon APTT
por: Hall, La'Teese, et al.
Publicado: (2014)

Serum albumin at resection predicts in-hospital death, while serum lactate and aPTT on the first postoperative day anticipate anastomotic leakage after Ivor-Lewis-esophagectomy
por: Scheufele, Florian, et al.
Publicado: (2022)

A case of syphilis presenting with prolonged etiology‐unrevealed fever, accompanying activated partial thromboplastin time prolongation
por: Yasuo, Kazuhiro
Publicado: (2018)

The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time
por: Samara, Evangelia, et al.
Publicado: (2021)

An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor
por: Ghafouri, Sanaz, et al.
Publicado: (2020)

International normalized ratio and activated partial thromboplastin time testing
por: Chornenki, Nicholas L. J., et al.
Publicado: (2022)

Investigation of active matrix- metaloproteinase-8 (aMMP-8) as a reference parameter for path control in antimicrobial photothermal therapy (aPTT) using a split-mouth design
por: Deumer, J., et al.
Publicado: (2019)

DIC Score: Statistical Relationship with PT, APTT, and Simplified Scoring Systems with Combinations of PT and APTT
por: Chandrashekar, Vani
Publicado: (2012)

Acquired Hemophilia of Unknown Etiology in an Elderly Man: Case Report
por: Stephen, Sonia Elvina, et al.
Publicado: (2018)

An Agreement Study Between Point-of-Care and Laboratory Activated Partial Thromboplastin Time for Anticoagulation Monitoring During Extracorporeal Membrane Oxygenation
por: Teng, Yuan, et al.
Publicado: (2022)

A Comparison of Activated Partial Thromboplastin Time and Activated Coagulation Time for Anticoagulation Monitoring during Extracorporeal Membrane Oxygenation Therapy
por: Liu, Ying, et al.
Publicado: (2022)

Comparative analysis on characteristics of two activated partial thromboplastin time reagents
por: Yasui, Yutaro, et al.
Publicado: (2022)

Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
por: Santoro, Rita Carlotta, et al.
Publicado: (2023)

Prominent Crystallization Promotion Effect of Montmorillonite on PTT/PC Blends with PTT as the Continuous Phase
por: Xue, Meiling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k9gh59b4o154opc63qee5qqdva